Beedimani, R. S., and B. Kalmath. “Canagliflozin: A Novel ‘glucuretic’ Approach for the Treatment of Type 2 Diabetes Mellitus”. International Journal of Basic & Clinical Pharmacology, vol. 3, no. 3, Jan. 2017, pp. 578-80, https://www.ijbcp.com/index.php/ijbcp/article/view/1032.